| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |